Alice Marceau‐Renaut

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association Group

Marie Balsat, Aline Renneville, Xavier Thomas et al. · Journal of Clinical Oncology · 2017 · 288 citations

Hematological Malignancy, Residual Disease, Transplantation +15

Comprehensive mutational profiling of core binding factor acute myeloid leukemia

Nicolas Duployez, Alice Marceau‐Renaut, Nicolas Boissel et al. · Blood · 2016 · 234 citations · Full text

<i>IDH1/2</i>but not<i>DNMT3A</i>mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

Houria Debarri, Delphine Lebon, Christophe Roumier et al. · Oncotarget · 2015 · 97 citations · Full text

Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia

Élise Fournier, Nicolas Duployez, Benoît Ducourneau et al. · Blood · 2019 · 82 citations · Full text

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Fleur Cohen‐Aubart, Damien Roos‐Weil, Marine Armand et al. · Blood · 2020 · 62 citations · Full text